Two Sigma Investments, LP Corvus Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 71,552 shares of CRVS stock, worth $343,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,552

Previous 47,786 49.73%

Holding current value

$343,449

Previous $86,000 338.37%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.78 - $5.92 $42,303 - $140,694	23,766 Added 49.73%	71,552 $377,000
Q2 2024 Aug 14, 2024	SELL	$1.36 - $2.29 $74,341 - $125,178	-54,663 Reduced 53.36%	47,786 $86,000
Q1 2024 May 15, 2024	SELL	$1.76 - $2.41 $137,728 - $188,594	-78,255 Reduced 43.31%	102,449 $182,000
Q4 2023 Feb 14, 2024	SELL	$1.08 - $1.92 $99,687 - $177,221	-92,303 Reduced 33.81%	180,704 $318,000
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.97 $26,441 - $55,696	18,753 Added 7.38%	273,007 $398,000
Q2 2023 Aug 14, 2023	BUY	$1.0 - $3.86 $50,207 - $193,799	50,207 Added 24.61%	254,254 $582,000
Q1 2023 May 15, 2023	SELL	$0.65 - $0.92 $50,141 - $70,968	-77,140 Reduced 27.43%	204,047 $185,000
Q4 2022 Feb 14, 2023	SELL	$0.74 - $1.04 $109,905 - $154,461	-148,521 Reduced 34.56%	281,187 $239,000
Q3 2022 Nov 14, 2022	BUY	$0.71 - $1.17 $48,758 - $80,348	68,674 Added 19.02%	429,708 $352,000
Q2 2022 Aug 15, 2022	SELL	$0.87 - $2.03 $124,515 - $290,535	-143,121 Reduced 28.39%	361,034 $357,000
Q1 2022 May 16, 2022	SELL	$1.46 - $2.48 $622,386 - $1.06 Million	-426,292 Reduced 45.82%	504,155 $827,000
Q4 2021 Feb 14, 2022	BUY	$2.34 - $5.31 $1.85 Million - $4.19 Million	789,992 Added 562.45%	930,447 $2.24 Million
Q3 2021 Nov 15, 2021	SELL	$1.89 - $8.53 $319,784 - $1.44 Million	-169,198 Reduced 54.64%	140,455 $680,000
Q2 2021 Aug 16, 2021	SELL	$2.46 - $3.14 $96,193 - $122,783	-39,103 Reduced 11.21%	309,653 $827,000
Q1 2021 May 17, 2021	BUY	$2.86 - $4.77 $997,442 - $1.66 Million	348,756 New	348,756 $1.07 Million
Q3 2020 Nov 16, 2020	SELL	$2.6 - $5.37 $132,017 - $272,667	-50,776 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.01 - $4.05 $97,448 - $196,352	-48,482 Reduced 48.84%	50,776 $138,000
Q1 2020 May 15, 2020	SELL	$1.74 - $5.98 $16,253 - $55,859	-9,341 Reduced 8.6%	99,258 $209,000
Q4 2019 Feb 14, 2020	BUY	$2.56 - $5.44 $114,050 - $242,357	44,551 Added 69.56%	108,599 $591,000
Q3 2019 Nov 14, 2019	BUY	$3.01 - $6.5 $51,603 - $111,436	17,144 Added 36.55%	64,048 $193,000
Q2 2019 Aug 14, 2019	SELL	$3.3 - $4.58 $55,958 - $77,663	-16,957 Reduced 26.55%	46,904 $175,000
Q1 2019 May 15, 2019	SELL	$3.75 - $4.97 $18,146 - $24,049	-4,839 Reduced 7.04%	63,861 $257,000
Q4 2018 Feb 14, 2019	BUY	$3.29 - $8.94 $226,023 - $614,178	68,700 New	68,700 $252,000

Others Institutions Holding CRVS

# of Institutions

Shares Held

30.4M

Call Options Held

1.06M

Put Options Held

84.3K

View Full List

About Corvus Pharmaceuticals, Inc.

Ticker CRVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,553,500
Market Cap $223M
Description
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...

More about CRVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Corvus Pharmaceuticals, Inc. Transaction History